Kuur Therapeutics

Now that Kymera Therapeutics Inc. has raised nearly $200m in venture capital to date – including a $102m series C round announced on 12 March – and entered into two collaborations with big pharma pa

The UK's new center for manufacturing cell and gene therapies can now start commercial production of such drugs after getting the go ahead from the Britain's Medicines and Healthcare Products Regulato

Leading immuno-oncology pioneer, Daniel Chen , has been appointed chief medical officer, a newly created position, at Mountain View, CA-based IGM Biosciences , to lead its clinical development act

This is a key moment in time, says Annalisa Jenkins, executive chair of Silence Therapeutics PLC , for both the company and the interfering RNA (RNAi) space, likening it to the development of antibod